Financhill
Back

Penumbra 10K Form

Sell
49

PEN
Penumbra

Last Price:
193.23
Seasonality Move:
-4.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive PEN News And Ratings

See the #1 stock for the next 7 days that we like better than PEN

PEN Financial Statistics

Sales & Book Value

Annual Sales: $747.59M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 7.63

Profitability

EPS (TTM): -0.51800
Net Income (TTM): $-19.39M
Gross Margin: $475.38M
Return on Equity: 0%
Return on Assets: -1.75%

Penumbra Earnings Forecast

Key Penumbra Financial Ratios

  • The Gross Profit Margin over the past 10 years for PEN is 63.59%.
  • The Selling, General & Administrative Expenses for PEN have been equal to 50.61% of Gross Profit Margin.
  • The Research & Development expenses have been 13.98% of Revenue.
  • The Net Earning history of PEN is 0.71% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 5 years.

Penumbra Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Medical Devices
Sector: Healthcare
Current Symbol: PEN
CUSIP: 70975L
Website: penumbrainc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 1380.21
Forward P/E Ratio: 160.72

PEN Technical Analysis vs Fundamental Analysis

Sell
49
Penumbra (PEN) is a Sell

Is Penumbra a Buy or a Sell?

  • Penumbra stock is rated a Sell
    The current Penumbra [PEN] share price is $193.23. The Score for PEN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.